MBA Students 2017


Male: 66%
Female: 34%
International: 11%

Years Out of Undergraduate School

< 2: 0
2-4: 46%
5-7: 48%
8 <: 6%

Undergraduate Majors

Liberal Arts and Social Sciences 18%
Sciences 15%
Engineering 15%
Business and Economics 45%
Pre-Professional 7%

Graduate Degrees Held

MD: 2
MD, PhD: 1
RN: 1
Joint MD/MBA Program: 6


79 Students


  • Andrea (“Andi”) Klestadt
    • I graduated with a BA from Yale in 2011, magna cum laude with honors in Cognitive Science. While in school I spent two summers abroad, studying Mandarin Chinese in Beijing then interning at a startup brand consulting firm in Shanghai. After graduation I joined the consulting firm ZS Associates in the New York office, where I primarily advised pharmaceutical and biotech companies. Many of my projects involved helping clients build forecast models and develop marketing, pricing, and sales strategies for the future launch of early stage pharmaceutical products in the US and Europe. I spent a lot of time speaking with physicians, key opinion leaders, nurses, payers, and patients in different countries to better understand market dynamics and unmet needs. Therapy areas I worked in include schizophrenia, oncology, psoriasis, pain management, opioid dependence, chronic kidney disease, infertility, and women’s health. While at ZS, I also co-chaired the Women’s Leadership Initiative group in the New York office.
  • Linan Xiao
    • I graduated from Duke University with a B.S. in Biology and minor in Chemistry and Chinese in 2009.  After four years as a proud Blue Devil, I joined a nonprofit called Princeton in Asia for a year, teaching English and developing course curricula at a Northern Thai university.  Then, I worked in the New York City practice of IMS Consulting Group, a global management advisory firm specializing in life sciences.  My role centered around providing strategic recommendations to large pharmaceutical and emerging biotechnology companies, particularly regarding global market access for innovative and established medicines.  Day to day, I served as the client liaison and project lead, conducted secondary and primary market research, analyzed IMS prescription and sales data sets, and synthesized findings to inform strategy for business unit and department leadership.  My project experience spans a range of pharmaceutical treatment areas in global markets, for example setting price for a novel oncology treatment in the US, assessing commercial opportunity for an orphan drug in Western Europe and identifying funding streams for a portfolio of innovative vaccine products in emerging markets.  The global nature of my company also provided me the opportunity for an 8 month secondement to the IMS Shanghai office, where I helped advocate for increased healthcare funding and access to medicines in China.
  • Jaeyoung Yang
    • I graduated from Yale in 2009 with a degree in economics and international studies. I have two work experiences before medical school: a stint as a congressional research assistant for Medicare and an assistant project manager for a healthcare nonprofit in Camden.